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Basile Pache, Peter Vollenweider, Gérard Waeber and Pedro Marques-Vidal*Abstract
Background: Little is known on the prevalence of multimorbidity (MM) in the general population. We aimed to
assess the prevalence of MM using measured or self-reported data in the Swiss population.
Methods: Cross-sectional, population-based study conducted between 2003 and 2006 in the city of Lausanne,
Switzerland, and including 3714 participants (1967 women) aged 35 to 75 years. Clinical evaluation was conducted
by thoroughly trained nurses or medical assistants and the psychiatric evaluation by psychologists or psychiatrists.
For psychiatric conditions, two definitions were used: either based on the participant’s statements, or on psychiatric
evaluation. MM was defined as presenting ≥2 morbidities out of a list of 27 (self-reported – definition A, or
measured – definition B) or as the Functional Comorbidity Index (FCI) using measured data – definition C.
Results: The overall prevalence and (95% confidence interval) of MM was 34.8% (33.3%-36.4%), 56.3% (54.6%-57.9%)
and 22.7% (21.4%-24.1%) for definitions A, B and C, respectively. Prevalence of MM was higher in women (40.2%, 61.7%
and 27.1% for definitions A, B and C, respectively, vs. 28.7%, 50.1% and 17.9% in men, p < 0.001); Swiss nationals (37.1%,
58.8% and 24.8% for definitions A, B and C, respectively, vs. 31.4%, 52.3% and 19.7% in foreigners, all p < 0.001); elderly
(>65 years: 67.0%, 70.0% and 36.7% for definitions A, B and C, respectively, vs. 23.6%, 50.2% and 13.8% for
participants <45 years, p < 0.001); participants with lower educational level; former smokers and obese participants.
Multivariate analysis confirmed most of these associations: odds ratio (95% Confidence interval) 0.55 (0.47-0.64), 0.61
(0.53-0.71) and 0.51 (0.42-0.61) for men relative to women for definitions A, B and C, respectively; 1.27 (1.09-1.49), 1.29
(1.11-1.49) and 1.41 (1.17-1.71) for Swiss nationals relative to foreigners, for definitions A, B and C, respectively.
Conversely, no difference was found for educational level for definitions A and B and abdominally obese participants
for all definitions.
Conclusions: Prevalence of MM is high in the Lausanne population, and varies according to the definition or the data
collection method.
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Multimorbidity (MM) is defined as the combined pres-
ence of several chronic pathologies in a subject [1]. MM
increases with age [2] and has been associated with a de-
crease in quality of life [3,4], with increased health care
utilization and cost [4,5] and with increased mortality [4],
although this latter statement has been challenged [6].* Correspondence: Pedro-Manuel.Marques-Vidal@chuv.ch
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unless otherwise stated.The definition of MM is far from consensual. A review
on the measures of MM in the clinical practice setting
listed 17 different measures, from disease counts to
more sophisticated indexes [7]. Another review collect-
ing data from 12 countries reported that the number of
health conditions analysed per study ranged from 5 to
335 [8]. This lack of standardization leads to a consider-
able difference in prevalence levels [9], which can range
from less than 5% to over 95% [8,10]. This lack of
standardization also leads to different associations with
health outcomes [11].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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among hospitalized patients or in clinical practices
[5,7,8,10,12-14]. Still, few studies have assessed the
prevalence of MM in Switzerland [14] and, to our know-
ledge, none has ever assessed the prevalence of MM in
the general population.
Therefore, the objective of this study was to assess the
prevalence of MM in a representative sample of the Swiss
population aged 35 to 75 years, using different MM defini-
tions and either reported or objectively assessed morbidity.
Methods
The Cohorte Lausannoise (CoLaus) study
The CoLaus study is a population-based study assessing
the clinical, biological and genetic determinants of car-
diovascular disease in the city of Lausanne, Switzerland.
Complete details of the sampling and clinical assessments
are provided elsewhere [15]. The study was approved by
the Institutional Ethics Committee of the University of
Lausanne and all participants provided written informed
consent. The initial recruitment took place between June
2003 and May 2006 and enrolled 6,733 participants (3,544
women) aged 35-75 years; participation rate was 41%. A
subset of 3,712 participants also had an extensive psychi-
atric evaluation [16]. Clinical evaluation was conducted
either by nurses or medical assistants who were trained
over a month period; psychiatric evaluation was con-
ducted either by psychologists or psychiatrists, who were
trained over a two-months period [16].
Clinical and anthropometric data
Educational level was categorized as primary, appren-
ticeship, secondary school and university. Smoking sta-
tus was defined as never, former and current. Receiving
social help was assessed with the question: “Do you re-
ceive social help?”. Because all individuals residing in
Switzerland receive financial compensation when they
retire, the response to this variable is not informative be-
yond the retirement age. Therefore, men older than
65 years and women older than 63 or 64 (depending on
sampling year, as retirement age changed for women
during the survey period) years were not considered as
receiving social help.
Body weight, height and waist circumference (WC) were
measured using standard procedures [15]. Body mass
index (BMI) was defined as weight(kg)/height(m)2. Over-
weight was defined as 25 ≤ BMI < 30 kg/m2 and obesity as
BMI ≥ 30 kg/m2. Abdominal obesity was defined as a waist
circumference ≥102 cm for men and ≥88 cm for women.
Multimorbidity
Multimorbidity was defined according to two sets of cri-
teria [12,17]. The first one [12] was chosen because of
the large sample size it was built upon and availability ofthe criteria in our study. For non-psychiatric conditions,
presence was established based either on self-report or
on the existence of a drug treatment. For psychiatric
conditions, two possibilities were assessed: either based
on the participant’s statements, or on psychiatric evalu-
ation. This was decided as most studies on MM rely on
self-report of psychiatric diseases and seldom use a com-
prehensive examination as in this study. As both self-
reported and objectively measured data were available,
two definitions were considered: definition A included
only self-reported morbidities, while in definition B all
available objectively measured morbidities (either diag-
nosed or assessed by an existing medication) replaced
the self-reported ones. These definitions are of interest
in a public health setting, but are difficult to implement
in clinical practice as they require the collection of a
large number of conditions.
Finally, a third definition (named C) was based on one
of the most used scores to assess MM, the Functional
Comorbidity Index (FCI) [17]. The criteria used for each
definition are indicated in the Additional file 1: Table S1.
This definition is based on a smaller number of condi-
tions and is easier to implement in clinical practice.
For each participant, the number of conditions present
according to each definition (see Additional file 1: Table S1)
was counted. For each definition, MM was defined if a
participant had more than 2 conditions, as performed
by others [12].Statistical analysis
Statistical analyses were conducted using Stata v.13
(Stata Corp, College Station, TX, USA). Descriptive re-
sults were expressed as average ± standard deviation or
as number of participants and (percentage). Bivariate
comparisons were performed using Student’s t-test or
one-way analysis of variance (ANOVA) for quantitative
data and chi-square for categorical data. Associations be-
tween MM scores were assessed using Spearman rank
correlation. Multivariate analysis was conducted using
multivariate ANOVA for number of pathologies and
using logistic regression for multimorbidity status (yes/
no). Results of the logistic regression were expressed as
odds ratio and (95% confidence interval). Statistical sig-
nificance was assessed for p < 0.05.Results
Characteristics of the participants
The characteristics of the sample according to gender
are summarized in Table 1. Women were older, less well
educated, more frequently non-smokers, had a lower
BMI and a lower prevalence of overweight and obesity.
No differences were found between genders regarding
social help or being born in Switzerland (Table 1).
Table 1 Clinical characteristics of the participants, by
gender
Women
(N = 1967)
Men
(N = 1747)
p-value
Age (years) 50.0 ± 8.8 49.1 ± 8.8 0.004
Educational level (%)
Primary 368 (18.7) 246 (14.1)
Apprenticeship 672 (34.2) 596 (34.1) <0.001
High school/college 559 (28.4) 442 (25.3)
University 368 (18.7) 463 (26.5)
Social help (%) 307 (15.6) 241 (13.8) 0.12
Born in Switzerland (%) 1210 (61.6) 1035 (59.2) 0.15
Smoking status (%)
Never 855 (43.5) 604 (34.6)
Former 566 (28.8) 627 (35.9) 0.001
Current 544 (27.7) 516 (29.5)
BMI (kg/m2) 24.8 ± 4.9 26.3 ± 3.8 <0.001
BMI categories (%)
Normal 1206 (61.4) 708 (40.5)
Overweight 516 (26.3) 787 (45.1) <0.001
Obese 243 (12.4) 252 (14.4)
Waist (cm) 82.1 ± 12.4 94.3 ± 10.9 <0.001
Abdominal obesity (%) 564 (28.7) 379 (21.7) <0.001
BMI, body mass index. Results are expressed as number of participants
(percentage) or as average ± standard deviation. Statistical analysis by chi-square
or Student’s t-test.
Table 2 Prevalence of multimorbidity according to three
different definitions and the participants’ characteristics
Definition A Definition B Definition C
All 1294 (34.8) 2089 (56.3) 845 (22.7)
Gender
Woman 790 (40.2) 1213 (61.7) 533 (27.1)
Man 502 (28.7) 876 (50.1) 312 (17.9)
p-value between groups <0.001 <0.001 <0.001
Age group
35-44 314 (23.6) 671 (50.2) 184 (13.8)
45-54 418 (33.9) 697 (56.7) 275 (22.4)
55-64 499 (47.1) 658 (62.3) 353 (33.4)
65+ 61 (67.0) 63 (70.0) 33 (36.7)
p-value between groups <0.001 <0.001 <0.001
Education
Primary 259 (42.2) 357 (58.1) 191 (31.1)
Apprenticeship 480 (37.9) 747 (58.9) 328 (25.9)
High school/college 319 (31.9) 555 (55.4) 203 (20.3)
University 236 (28.4) 430 (51.7) 123 (14.8)
p-value between groups <0.001 <0.01 <0.001
Receiving social help
No 1004 (31.7) 1708 (54.0) 625 (19.7)
Yes 290 (52.9) 381 (69.5) 220 (40.2)
p-value between groups <0.001 <0.001 <0.001
Born in Switzerland
No 460 (31.4) 768 (52.3) 289 (19.7)
Yes 832 (37.1) 1321 (58.8) 556 (24.8)
p-value between groups <0.001 <0.001 <0.001
Smoking
Never 440 (30.2) 714 (48.9) 288 (19.7)
Former 462 (38.7) 721 (60.4) 304 (25.5)
Current 390 (36.8) 654 (61.6) 253 (23.9)
p-value between groups <0.001 <0.001 0.001
BMI status
Normal 560 (29.3) 1054 (55.0) 302 (15.8)
Overweight 470 (36.1) 700 (53.7) 235 (18.0)
Obese 262 (52.9) 335 (67.5) 308 (62.1)
p-value between groups <0.001 <0.001 <0.001
Abdominal obesity
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The prevalence of MM according to the three definitions
considered and with several characteristics of the partici-
pants is summarized in Table 2.
The overall prevalence of MM using measured mor-
bidities (definition B) was the highest, followed by MM
using reported morbidities (definition A) and MM ac-
cording to FCI (definition C). Significant (p < 0.001) cor-
relations were found between MM scores (Additional
file 2: Figures S1-S3), with Spearman r = 0.744 between
definitions A and B, r = 0.560 between definitions B and
C, and r = 0.765 between definitions A and C. The num-
ber of participants diagnosed with MM according to
each definition is indicated in Figure 1. Only one third
(33.7%) of participants diagnosed with MM was jointly
diagnosed by all three definitions considered.No 830 (30.0) 1474 (53.2) 435 (15.7)
Yes 464 (49.2) 615 (65.2) 410 (43.4)
p-value between groups <0.001 <0.001 <0.001
Results are expressed as number of participants (percentage) presenting with
the condition. BMI, body mass index. Definitions A and B based on [12].
Definition C based on the Functional Comorbidity Index [17]. For more details,
please consult Additional file 1: Table S1. Statistical analysis between groups
stratified on the definition of multimorbidity using chi-square.Determinants of multimorbidity
Irrespective of the definition used, the prevalence of
MM was higher in women, among participants receiving
social help and among current and former smokers. The
prevalence of MM also increased considerably with age
and obesity (defined by BMI or increased waist) and
with decreasing educational level (Table 2).
Figure 1 Venn diagram showing the prevalence of multimorbidity according to the definitions considered. Definition A, using reported
morbidities; definition B, using measured morbidities; definition C, using Functional Comorbidity Index (FCI) criteria.
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associated with each definition of MM are summarized
in Table 3. For all definitions of MM considered, men
had a lower likelihood of presenting MM than women.
Older age, receiving social help, being born in
Switzerland, being a former or a current smoker and be-
ing obese were significantly and independently associ-
ated with a higher likelihood of presenting MM. No
effect of educational level was found for definitions A
and B of MM, while for definition C a protective effect
of education was found. No association was found be-
tween abdominal obesity and MM for all three defini-
tions of MM considered.
Discussion
To our knowledge, this is one of the few studies that
assessed the prevalence of MM using a population-based
sample and the first of its kind in Switzerland. Our re-
sults show that MM is relatively common in an appar-
ently healthy general population. Our results also show
that the prevalence of MM varies significantly according
to the criteria used and even according to the data col-
lection method (reported or measured).
Prevalence of multimorbidity
Prevalence of MM varied considerably according to the
criteria used, a finding already reported in the literature
[9,11], although this statement has been challenged [14].
Even using the same set of criteria, the prevalence varied
considerably when self-reported or measured data was
collected, a finding also noted when using data from
electronic records or from health surveys [18,19]. Alikely explanation is that many subjects are unaware of
their status, as it has been shown for cardiovascular risk
factors such as hypertension [20] or type 2 diabetes [21].
The lower prevalence of MM according to the FCI
might also be due to the fact that the number of criteria
is lower than the other definitions. Hence, a condition
present in definitions A and B might not be considered
as such with the FCI definition. Our results suggest that
the prevalence of MM depends on the number of condi-
tions considered, the higher the number the higher the
likelihood of being diagnosed with MM. A possible (but
not optimal) solution would be to modulate the thresh-
old according to the number of criteria used to facilitate
comparison between studies: for instance, MM could be
diagnosed if a participant has 30% of all conditions, in-
stead of a fixed number of conditions. Another possibil-
ity would be to select different definitions of MM
according to the objective of the study [11], but this pos-
sibility would limit comparisons to studies with the same
aims.
Although significant correlations were found between
the number of reported or measured morbidities, still no
good agreement was found between definitions, as only
one third of participants diagnosed with MM by at least
one definition was jointly diagnosed as MM by all three
definitions. Our results thus stress the need for a com-
mon, standard definition of MM, which will allow com-
parison between studies.
The high prevalence of MM in our study also raises
the question of the adequate management of subjects
with MM. Indeed, health care providers are usually
trained to manage one disease at the time (single-disease
Table 3 multivariate analysis of factors associated with multimorbidity according to three definitions
Definition A Definition B Definition C
Gender
Woman 1 (ref.) 1 (ref.) 1 (ref.)
Man 0.55 (0.47 - 0.64) 0.61 (0.53 - 0.71) 0.51 (0.42 - 0.61)
Age group
35-44 1 (ref.) 1 (ref.) 1 (ref.)
45-54 1.59 (1.33 - 1.91) 1.24 (1.05 - 1.45) 1.73 (1.39 - 2.17)
55-64 2.45 (2.03 - 2.95) 1.44 (1.21 - 1.71) 2.52 (2.01 - 3.16)
65+ 6.91 (4.28 - 11.1) 2.31 (1.43 - 3.71) 3.36 (2.01 - 5.62)
p-value for trend <0.001 <0.001 <0.001
Education
Primary 1 (ref.) 1 (ref.) 1 (ref.)
Apprenticeship 0.84 (0.67 - 1.04) 1.00 (0.81 - 1.24) 0.81 (0.63 - 1.05)
High school/college 0.77 (0.61 - 0.96) 0.98 (0.79 - 1.22) 0.76 (0.58 - 0.99)
University 0.82 (0.64 - 1.04) 0.99 (0.79 - 1.24) 0.68 (0.50 - 0.91)
p-value for trend 0.11 0.99 <0.05
Receiving social help
No 1 (ref.) 1 (ref.) 1 (ref.)
Yes 2.40 (1.97 - 2.92) 1.92 (1.56 - 2.35) 2.74 (2.19 - 3.41)
Born in Switzerland
No 1 (ref.) 1 (ref.) 1 (ref.)
Yes 1.27 (1.09 - 1.49) 1.29 (1.11 - 1.49) 1.41 (1.17 - 1.71)
Smoking
Never 1 (ref.) 1 (ref.) 1 (ref.)
Former 1.54 (1.30 - 1.84) 1.69 (1.44 - 1.98) 1.55 (1.26 - 1.91)
Current 1.51 (1.26 - 1.80) 1.79 (1.51 - 2.11) 1.51 (1.21 - 1.87)
p-value for trend <0.001 <0.001 <0.001
BMI status
Normal 1 (ref.) 1 (ref.) 1 (ref.)
Overweight 1.33 (1.11 - 1.59) 0.94 (0.80 - 1.11) 1.10 (0.88 - 1.38)
Obese 2.18 (1.63 - 2.92) 1.41 (1.06 - 1.88) 7.53 (5.40 - 10.5)
p-value for trend <0.001 0.16 <0.001
Abdominal obesity
No 1 (ref.) 1 (ref.) 1 (ref.)
Yes 1.16 (0.93 - 1.45) 1.22 (0.98 - 1.51) 1.24 (0.96 - 1.60)
Results are expressed as Odds ratio and (95% confidence interval). BMI, body mass index. Definitions A and B based on [12]. Definition C based on the Functional
Comorbidity Index [17]. For more details, please consult Additional file 1: Table S1. Statistical analysis by multivariate logistic regression adjusting simultaneously
for all parameters indicated.
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tions. Our results thus question the current status of med-
ical training and of the medical system, and indicate that
future medical education should bring back together dif-
ferent branches of medicine, as already postulated [22].
Determinants of multimorbidity
Women had higher rates of MM than men, and this as-
sociation was confirmed after multivariate adjustment.These findings are in agreement with some studies
[12,23] but not with others [2,14,24]. One explanation is
that women are more sensitized to their health status
and thus tend to report more conditions (Additional file
1: Table S2), but this should not influence MM defined
according to objectively measured data, although the
prevalence of objectively assessed psychiatric diseases
was higher in women than in men (Additional file 1:
Table S2). Overall, our results indicate that MM is more
Pache et al. BMC Public Health  (2015) 15:164 Page 6 of 8prevalent in Swiss women than in Swiss men, and that
this difference is independent from other demographic,
clinical or socio-economic characteristics.
Prevalence of MM increased considerably with age, a
finding also reported in the literature [2,12,14,23]. This
was mainly due to the increase in the overall number of
participants with at least one condition (Additional file
2: Figures S4-S6). Indeed, age is related to functional de-
cline and to an increase in the number of morbid condi-
tions. Interestingly, the difference in the prevalence of
MM using self-reported and measured data tended nar-
row with increasing age. This narrowing could be ex-
plained by a better awareness or a better diagnosis of the
diseases; indeed, it has been shown that a significant per-
centage of cardiovascular risk factors are undiagnosed
[20,21,25]. Overall, our results confirm that age is a
strong determinant of MM, and that MM is prevalent
even among young adults, a finding also reported else-
where [26]. More importantly, our results suggest that,
in developed countries, the total number of patients with
MM will considerably increase in the forthcoming years
because of the ageing population, with considerable im-
pact on health care costs [27].
In agreement with other studies [28,29], prevalence of
MM was higher among obese participants. The consid-
erable increase of MM as defined by FCI among obese
participants is easily explained by the fact that obesity is
a criterion for MM according to FCI. Overall, our results
reflect the clustering of risk factors and morbidities
among obese subjects [29,30], and in future studies it
will be of interest the joint trends in obesity and MM,
namely in the younger population. Finally, the positive
association between abdominal obesity and MM initially
found on bivariate analysis became non-significant after
multivariate analysis.
Being a former or current smoker was related to a
higher prevalence of MM, a finding also reported previ-
ously [26]. As for obesity, the most likely explanation is
the tobacco-induced increase of multiple morbid condi-
tions. Hence and again, early smoking cessation should
be offered to all current smokers in order to decrease
their risk of disease and, consequently, of MM.
Low socio economic status, defined by a low education
or by receiving social help, was positively associated with
MM, although the association between educational level
and MM was significant for the FCI definition only. Our
results are in agreement with several studies [2,12,31,32]
but not with another [33]. Possible explanations include
the deleterious effect of working environment together
with inadequate health behaviours among low SES groups.
Overall, our results suggest that preventive measures
should be directed to low SES groups, but such measures
are different to implement [34] and their effects are con-
troversial [35].Swiss citizenship was positively associated with MM.
This finding was somewhat unexpected as in Switzerland
access to health care is available for all. Further, to our
knowledge, no study ever focused on MM in migrants.
Thus, reasons for this difference are not straightforward
and can only be speculated. One possible explanation
would be a higher use of the healthcare system by Swiss
nationals, which would increase the likelihood of detecting
diseases. Another possible explanation would be better
health behaviours of migrants relatively to Swiss nationals
[36], but future studies are needed to better assess this
point.
Strengths and limitations
This study has several strengths. It was conducted on an
apparently healthy, population-based sample. It also col-
lected data on self-reported and measured morbidities,
allowing the comparison of the two data collection
methods.
This study has also several limitations. The participa-
tion rate (41%) was relatively low, although in line or
event higher than other epidemiological studies [37,38].
Hence, a selection bias cannot be ruled out, subjects
presenting with morbidities being more prone to refuse
to participate. Similarly, some participants might have
forgotten to report some diseases or incorrectly reported
them. Still, this would lead to an underestimation of the
true prevalence of MM within the target population;
thus, we believe that our prevalence estimates, although
relatively high, are even though rather conservative. Due
to its cross-sectional design, no association could be
made between MM severity and quality of life or mortal-
ity. The ongoing follow-up of the CoLaus cohort will en-
able assessing the trends in the prevalence of MM and
the associations between the different definitions of MM
and mortality. Finally, in Switzerland, matching of med-
ical electronic records with information from surveys is
not allowed. Thus, it was not possible to confirm the
statements of the participants from electronic records.
Still, several studies have shown a discrepancy between
data collected by surveys and extracted from electronic
health records [18,19]: depending on the disease of inter-
est, the prevalence obtained from electronic records
could be similar, higher or lower than the prevalence re-
ported in the survey, with further variations according
to age and sex [19].
Conclusion
Prevalence of MM in the general population varies con-
siderably according to the definition used. Increased
age, female gender, tobacco smoking, obesity and low
socioeconomic status significantly increase the likeli-
hood of MM. The effect of migration awaits further
investigation.
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